Medidata Solutions (MDSO) 54.85 $MDSO Medidata
Post# of 273257
Posted On: 09/03/2016 3:11:14 AM
Medidata Solutions (MDSO) 54.85 $MDSO
Medidata to Present at Citi 2016 Global Technology Conference
BusinessWire - Thu Sep 01, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Mike Capone, chief operating officer, and Rouven Bergmann, chief financial officer, will present at the Citi 2016 Global Technology Conference on Tuesday, September 6, 2016, at 3:05 p.m. ET in New York.
MDSO: 54.85 (+1.12)
SHYFT Analytics Raises $12.5 Million in New Funding From Global Healthcare and Technology Leaders, Led by McKesson Ventures and Medidata Solutions
Marketwired - Tue Aug 30, 7:30AM CDT
Strategic Investments to Accelerate Growth Fueled by Demand for Healthcare Analytics
MDSO: 54.85 (+1.12)
Medidata Solutions Reaches Analyst Target Price
ETFChannel.com - Wed Aug 24, 6:50AM CDT
In recent trading, shares of Medidata Solutions, Inc. have crossed above the average analyst 12-month target price of $53.86, changing hands for $55.01/share.
MDSO: 54.85 (+1.12)
Pluristem Therapeutics Deploys Medidata's Cloud Technology
BusinessWire - Wed Aug 03, 2:00AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, announced today that its cloud technology platform has been adopted by Pluristem Therapeutics Inc. (NasdaqCM: PSTI, TASE: PSTI/PLTR). The Israeli biotech will deploy Medidata Rave(R) to capture, manage and maximize the value of its clinical data.
MDSO: 54.85 (+1.12), PSTI: 1.65 (+0.01)
Medidata to Present at Pacific Crest Global Technology Leadership Conference
BusinessWire - Tue Aug 02, 4:30PM CDT
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann, chief financial officer, will present at the 18th Annual Pacific Crest Global Technology Leadership Conference on Monday, August 8, 2016, at 9:30 a.m. MT (11:30 a.m. ET) in Vail, Colorado.
MDSO: 54.85 (+1.12)
Medidata's April Mulroney Honored Among PharmaVOICE 100's Most Inspiring People
BusinessWire - Mon Aug 01, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, is pleased to announce that its own April Mulroney has been recognized by PharmaVOICE magazine as one of the 100 most inspiring people in the life sciences industry.
MDSO: 54.85 (+1.12)
New Cancer-Focused Biotech Forty Seven Inc. Selects Medidata to Accelerate Novel Immuno-Oncology R&D
BusinessWire - Thu Jul 28, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Forty Seven Inc., a new biotechnology company specializing in cancer immunotherapy, is powering two upcoming anti-cancer studies with the Medidata Clinical Cloud(R).
MDSO: 54.85 (+1.12)
Uptrend Call Working As Medidata Solutions Stock Rises 19.4% (MDSO)
Comtex SmarTrend(R) - Tue Jun 21, 1:57PM CDT
SmarTrend identified an Uptrend for Medidata Solutions (NASDAQ:MDSO) on March 30th, 2016 at $37.96. In approximately 3 months, Medidata Solutions has returned 19.38% as of today's recent price of $45.31.
MDSO: 54.85 (+1.12)
Moving Average Crossover Alert: Medidata (MDSO)
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:46AM CDT
Medidata Solutions, Inc. (MDSO) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
MDSO: 54.85 (+1.12)
24.3% Return Seen to Date on SmarTrend Medidata Solutions Call (MDSO)
Comtex SmarTrend(R) - Mon Jun 13, 1:53PM CDT
SmarTrend identified an Uptrend for Medidata Solutions (NASDAQ:MDSO) on March 30th, 2016 at $37.96. In approximately 3 months, Medidata Solutions has returned 24.25% as of today's recent price of $47.16.
MDSO: 54.85 (+1.12)
Why Medidata Solutions (MDSO) Could Be an Impressive Growth Stock
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:42AM CDT
Medidata Solutions (MDSO) looks like an exciting pick for investors as it is poised for strong future growth.
MDSO: 54.85 (+1.12)
Can Medidata Solutions (MDSO) Keep the Earnings Streak Alive This Quarter?
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 7:59AM CDT
Medidata Solutions (MDSO) currently has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
MDSO: 54.85 (+1.12)
Medidata Solutions Has Returned 19.0% Since SmarTrend Recommendation (MDSO)
Comtex SmarTrend(R) - Fri Jun 03, 1:58PM CDT
SmarTrend identified an Uptrend for Medidata Solutions (NASDAQ:MDSO) on March 30th, 2016 at $37.96. In approximately 2 months, Medidata Solutions has returned 19.04% as of today's recent price of $45.18.
MDSO: 54.85 (+1.12)
Omnicell Grows amid Weak Margins, Hospital Spending Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:57AM CDT
On Jun 1, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDSO: 54.85 (+1.12), DRAD: 5.26 (+0.12), OMCL: 38.88 (+0.58), ATHN: 123.61 (+0.48)
Medidata Invites Investors and Analysts to Join Webcast on June 2, 2016
BusinessWire - Fri May 27, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced it will host a webcast for investors and analysts on Thursday, June 2, 2016 at 3:00 p.m. ET. The one-hour webcast will focus on the Company's recent European Symposium, where Medidata clients and partners from more than 60 organizations across 16 countries convened to network, exchange ideas, share best practices and provide feedback.
MDSO: 54.85 (+1.12)
Short Interest In Medidata Solutions Expands By 10.8%
MarketNewsVideo.com - Wed May 25, 12:54PM CDT
The most recent short interest data has been released for the 05/13/2016 settlement date, which shows a 546,916 share increase in total short interest for Medidata Solutions, Inc. , to 5,621,428, an increase of 10.78% since 04/29/2016.
MDSO: 54.85 (+1.12)
Evolent (EVH) Q1 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri May 13, 7:14AM CDT
Evolent (EVH) reported loss of 24 cents per share, wider than the Zacks Consensus Estimate of a loss of 19 cents.
EVH: 24.94 (-0.09), MDSO: 54.85 (+1.12), QSII: 11.86 (+0.08), ATHN: 123.61 (+0.48)
Medidata's April Mulroney Named an Industry "Rising Star" by the Healthcare Businesswomen's Association
BusinessWire - Thu May 12, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, is pleased to announce that April Mulroney has been named a 2016 industry "Rising Star" by the Healthcare Businesswomen's Association (HBA). She will be recognized at the HBA's 27th Woman of the Year (WOTY) event, held Thursday, May 12, in New York City.
MDSO: 54.85 (+1.12)
Allscripts (MDRX) Posts In-Line Q1 Earnings; FY16 View Up
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:01AM CDT
Allscripts Healthcare Solutions Inc. (MDRX) reported adjusted earnings of 13 cents per share in the first quarter of 2016, which surged 62.5% from the year-ago quarter.
MDSO: 54.85 (+1.12), MDRX: 12.88 (-0.03), QSII: 11.86 (+0.08), ATHN: 123.61 (+0.48)
Medidata to Present at Citi 2016 Global Technology Conference
BusinessWire - Thu Sep 01, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Mike Capone, chief operating officer, and Rouven Bergmann, chief financial officer, will present at the Citi 2016 Global Technology Conference on Tuesday, September 6, 2016, at 3:05 p.m. ET in New York.
MDSO: 54.85 (+1.12)
SHYFT Analytics Raises $12.5 Million in New Funding From Global Healthcare and Technology Leaders, Led by McKesson Ventures and Medidata Solutions
Marketwired - Tue Aug 30, 7:30AM CDT
Strategic Investments to Accelerate Growth Fueled by Demand for Healthcare Analytics
MDSO: 54.85 (+1.12)
Medidata Solutions Reaches Analyst Target Price
ETFChannel.com - Wed Aug 24, 6:50AM CDT
In recent trading, shares of Medidata Solutions, Inc. have crossed above the average analyst 12-month target price of $53.86, changing hands for $55.01/share.
MDSO: 54.85 (+1.12)
Pluristem Therapeutics Deploys Medidata's Cloud Technology
BusinessWire - Wed Aug 03, 2:00AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, announced today that its cloud technology platform has been adopted by Pluristem Therapeutics Inc. (NasdaqCM: PSTI, TASE: PSTI/PLTR). The Israeli biotech will deploy Medidata Rave(R) to capture, manage and maximize the value of its clinical data.
MDSO: 54.85 (+1.12), PSTI: 1.65 (+0.01)
Medidata to Present at Pacific Crest Global Technology Leadership Conference
BusinessWire - Tue Aug 02, 4:30PM CDT
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann, chief financial officer, will present at the 18th Annual Pacific Crest Global Technology Leadership Conference on Monday, August 8, 2016, at 9:30 a.m. MT (11:30 a.m. ET) in Vail, Colorado.
MDSO: 54.85 (+1.12)
Medidata's April Mulroney Honored Among PharmaVOICE 100's Most Inspiring People
BusinessWire - Mon Aug 01, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, is pleased to announce that its own April Mulroney has been recognized by PharmaVOICE magazine as one of the 100 most inspiring people in the life sciences industry.
MDSO: 54.85 (+1.12)
New Cancer-Focused Biotech Forty Seven Inc. Selects Medidata to Accelerate Novel Immuno-Oncology R&D
BusinessWire - Thu Jul 28, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Forty Seven Inc., a new biotechnology company specializing in cancer immunotherapy, is powering two upcoming anti-cancer studies with the Medidata Clinical Cloud(R).
MDSO: 54.85 (+1.12)
Uptrend Call Working As Medidata Solutions Stock Rises 19.4% (MDSO)
Comtex SmarTrend(R) - Tue Jun 21, 1:57PM CDT
SmarTrend identified an Uptrend for Medidata Solutions (NASDAQ:MDSO) on March 30th, 2016 at $37.96. In approximately 3 months, Medidata Solutions has returned 19.38% as of today's recent price of $45.31.
MDSO: 54.85 (+1.12)
Moving Average Crossover Alert: Medidata (MDSO)
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:46AM CDT
Medidata Solutions, Inc. (MDSO) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
MDSO: 54.85 (+1.12)
24.3% Return Seen to Date on SmarTrend Medidata Solutions Call (MDSO)
Comtex SmarTrend(R) - Mon Jun 13, 1:53PM CDT
SmarTrend identified an Uptrend for Medidata Solutions (NASDAQ:MDSO) on March 30th, 2016 at $37.96. In approximately 3 months, Medidata Solutions has returned 24.25% as of today's recent price of $47.16.
MDSO: 54.85 (+1.12)
Why Medidata Solutions (MDSO) Could Be an Impressive Growth Stock
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:42AM CDT
Medidata Solutions (MDSO) looks like an exciting pick for investors as it is poised for strong future growth.
MDSO: 54.85 (+1.12)
Can Medidata Solutions (MDSO) Keep the Earnings Streak Alive This Quarter?
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 7:59AM CDT
Medidata Solutions (MDSO) currently has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
MDSO: 54.85 (+1.12)
Medidata Solutions Has Returned 19.0% Since SmarTrend Recommendation (MDSO)
Comtex SmarTrend(R) - Fri Jun 03, 1:58PM CDT
SmarTrend identified an Uptrend for Medidata Solutions (NASDAQ:MDSO) on March 30th, 2016 at $37.96. In approximately 2 months, Medidata Solutions has returned 19.04% as of today's recent price of $45.18.
MDSO: 54.85 (+1.12)
Omnicell Grows amid Weak Margins, Hospital Spending Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:57AM CDT
On Jun 1, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDSO: 54.85 (+1.12), DRAD: 5.26 (+0.12), OMCL: 38.88 (+0.58), ATHN: 123.61 (+0.48)
Medidata Invites Investors and Analysts to Join Webcast on June 2, 2016
BusinessWire - Fri May 27, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced it will host a webcast for investors and analysts on Thursday, June 2, 2016 at 3:00 p.m. ET. The one-hour webcast will focus on the Company's recent European Symposium, where Medidata clients and partners from more than 60 organizations across 16 countries convened to network, exchange ideas, share best practices and provide feedback.
MDSO: 54.85 (+1.12)
Short Interest In Medidata Solutions Expands By 10.8%
MarketNewsVideo.com - Wed May 25, 12:54PM CDT
The most recent short interest data has been released for the 05/13/2016 settlement date, which shows a 546,916 share increase in total short interest for Medidata Solutions, Inc. , to 5,621,428, an increase of 10.78% since 04/29/2016.
MDSO: 54.85 (+1.12)
Evolent (EVH) Q1 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri May 13, 7:14AM CDT
Evolent (EVH) reported loss of 24 cents per share, wider than the Zacks Consensus Estimate of a loss of 19 cents.
EVH: 24.94 (-0.09), MDSO: 54.85 (+1.12), QSII: 11.86 (+0.08), ATHN: 123.61 (+0.48)
Medidata's April Mulroney Named an Industry "Rising Star" by the Healthcare Businesswomen's Association
BusinessWire - Thu May 12, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, is pleased to announce that April Mulroney has been named a 2016 industry "Rising Star" by the Healthcare Businesswomen's Association (HBA). She will be recognized at the HBA's 27th Woman of the Year (WOTY) event, held Thursday, May 12, in New York City.
MDSO: 54.85 (+1.12)
Allscripts (MDRX) Posts In-Line Q1 Earnings; FY16 View Up
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:01AM CDT
Allscripts Healthcare Solutions Inc. (MDRX) reported adjusted earnings of 13 cents per share in the first quarter of 2016, which surged 62.5% from the year-ago quarter.
MDSO: 54.85 (+1.12), MDRX: 12.88 (-0.03), QSII: 11.86 (+0.08), ATHN: 123.61 (+0.48)
(0)
(0)Scroll down for more posts ▼